About EarlySight
EarlySight is a company based in Lausanne (Switzerland) founded in 2016 by Francine Behar-Cohen, Mathieu Kunzi, and Timothe Laforest. EarlySight has raised $6.56 million across 5 funding rounds from investors including Zurcher Kantonalbank, EIT Health and CADFEM. EarlySight offers products and services including Cellularis Discovery. EarlySight operates in a competitive market with competitors including Optomed, Eyenuk, LKC Technologies, Heidelberg Engineering and Wooptix, among others.
- Headquarter Lausanne, Switzerland
- Founders Francine Behar-Cohen, Mathieu Kunzi, Timothe Laforest
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Earlysight Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.56 M (USD)
in 5 rounds
-
Latest Funding Round
$3.88 M (USD), Seed
Sep 08, 2025
-
Investors
Zurcher Kantonalbank
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EarlySight
EarlySight offers a comprehensive portfolio of products and services, including Cellularis Discovery.
Provides cellular-level images of retina for disease detection and monitoring.
People of EarlySight
Unlock access to complete
Unlock access to complete
Funding Insights of EarlySight
EarlySight has successfully raised a total of $6.56M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $3.88 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EarlySight
EarlySight has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Zurcher Kantonalbank, EIT Health and CADFEM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated and supported by Fongit in Switzerland.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on science and tech-driven startups
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for EarlySight
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EarlySight
Investment portfolio details for EarlySight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EarlySight
Detailed financials for EarlySight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Earlysight Comparisons
Peer comparison for EarlySight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EarlySight
EarlySight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Optomed, Eyenuk, LKC Technologies, Heidelberg Engineering and Wooptix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of handheld fundus cameras and software solutions for eye screening
|
|
| Locked | Locked | Locked |
AI-driven retinal image analysis for diabetic retinopathy detection is developed.
|
|
| Locked | Locked | Locked |
Non-mydriatic hand-held devices for visual electrophysiology testing are developed.
|
|
| Locked | Locked | Locked |
Diagnostic imaging devices are developed for early eye disease detection.
|
|
| Locked | Locked | Locked |
Application that allows 3D capture using single standard camera
|
Detailed competitors of EarlySight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Earlysight
Complete news archive for EarlySight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EarlySight
EarlySight was founded in 2016 and raised its 1st funding round 3 years after it was founded.
EarlySight is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Timothe Laforest is the current CEO of EarlySight. They have also founded this company.
EarlySight is a funded company, having raised a total of $6.56M across 5 funding rounds to date.
EarlySight was founded in 2016 and is based in Lausanne, Switzerland. Retinal imaging technologies are developed for ophthalmologists to visualize disease origins, including age-related macular degeneration. Measurements of retinal cell density and size are enabled. Micro-vasculature structures and small capillaries in retinal disorders are observed through these solutions in the health technology sector.
EarlySight's top competitors include Heidelberg Engineering, Eyenuk and Optomed.
EarlySight offers Cellularis Discovery.
EarlySight has 8 investors. Key investors include Zurcher Kantonalbank, EIT Health, CADFEM, Fongit, and Verve Ventures.